Bitnomial Exchange, a CFTC-regulated designated contract market, has listed INJ monthly futures — making Injective the first asset outside BTC and ETH to get regulated U.S. derivatives infrastructure on the platform. The listing is strategically significant because it starts a six-month clock toward potential SEC approval of Canary Capital's staked INJ ETF under generic listing standards, with Cboe BZX already filing a 19b-4 listing application. Bitnomial's retail arm Botanical will open INJ futures access in the coming weeks, and the exchange plans to add perpetuals and options next.

TLDR by @Benthic

More coverage

Explore the topic

More on CFTC

Comments